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The central role of nuclear factor-kB in mesangial cell activa- example, by using neutralizing antibodies against plate-
tion. let-derived growth factor (PDGF), have proven effective
Background. Nuclear factor-kB (NF-kB) is a family of tran- in reducing proliferation in experimental models [3].scription factors that is recognized by the kB enhancer element.
However, because mesangial cell activation is likely toNumerous proinflammatory genes have binding sites for NF-kB,
reflect a mosaic of numerous proinflammatory mole-and the products of these genes are an integral part of cellular
activation and inflammatory response systems. Because there cules, it may be difficult to target only one or two proin-
is a close relationship between NF-kB and mediators of cell flammatory molecules for the therapy of renal disease.
activation, it is possible that a disruption of NF-kB–activating
On the other hand, it may be possible to block intracellu-pathways may effectively influence mesangial cell activation.
lar signals, which are common to several proinflamma-Methods. We reviewed available studies related to both NF-kB
and mesangial cells in order to provide evidence for the role tory molecules, and thereby inhibit induction and/or
of NF-kB in mesangial cell activation. transcription of proinflammatory molecule genes that
Results. Studies reported by this laboratory and others cause mesangial cell activation.showed that various experimental maneuvers that modulate
The regulatory repertoire of transcription factor fami-NF-kB activation result in a parallel modulation of proinflam-
lies appears to be pivotal for the modulation of genematory molecule production in cultured mesangial cells. Like-
wise, the ability of the inhibitors of NF-kB activation to down- expression. One such regulatory network is composed
regulate the inflammatory response in animal models of renal of a family of ubiquitous gene transactivators known as
disease has been recently demonstrated.
nuclear factor-kB (NF-kB). Numerous proinflammatoryConclusions. These data suggest a pivotal role of NF-kB in
genes have binding sites for NF-kB, and the products ofmesangial cell activation and designate it as an obvious target
for the modulation of this activation. Studies are necessary to these genes are an integral part of cellular activation and
characterize the role of NF-kB in human renal injury. inflammatory response systems [4, 5]. Because there is
a close relationship between NF-kB and mediators of
cell activation, it is possible that disruption of NF-kB–
Mesangial cell activation has been demonstrated to activating pathways may effectively influence mesangial
occur in a large number of experimental models of renal cell activation.
disease, as well as in various human renal diseases [1, 2].
After mesangial injury caused by any of several factors,
NUCLEAR FACTOR-kBincluding immunological and metabolic factors, a pleth-
ora of adhesion molecules, chemokines, proinflamma- Nuclear factor-kB is a family of dimeric proteins that
tory cytokines, and inflammatory enzymes appears to belong to the Rel family. They are distinguished by a
cause or at least contribute to the inflammatory and homologous domain of approximately 300 amino acids,
proliferative responses of the mesangial cell [1, 2]. These the Rel homology domain, that determines dimeriza-
proinflammatory molecules are, in part, produced by tion, nuclear localization, and binding to kB element
mesangial cells [1, 2]. Therapeutic approaches aimed at (59-GGGPuNNPyPyCC-39) in the promoter and enhancer
antagonizing individual proinflammatory molecules, for regions of target genes. By far the most common type
of dimer comprises a p50 subunit bound to a p65 (Rel
A) subunit; however, other Rel proteins (c-Rel, Rel B,Key words: angiotensin-converting enzyme inhibitor, cytokines, lova-
statin, mesangial cells, transcription factors. v-Rel, and p52) are also described, and various combina-
tions are possible [4–6]. It should be noted that p50 and 1999 by the International Society of Nephrology
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p52 are synthesized as precursor proteins of 105 and tion in cultured mesangial cells [7–17]. We have demon-
strated that LPS stimulated human mesangial cells to100 kDa, respectively, and are generated by proteolytic
processing [4–6]. The other Rel proteins are not synthe- exhibit an NF-kB–like activity, as assessed by electro-
phoretic mobility shift assays (EMSA) and supershiftsized as precursors. NF-kB is normally held in the cyto-
plasm of unstimulated cells in an inactive form bound assays with antibodies against p50 and p65 subunits of
NF-kB [7]. Two recent works have established that theto an inhibitory protein, IkB, of which several types
are recognized (IkB-a, IkB-b, and IkB-g) [4–6]. IkB exposure of mouse and human mesangial cells to aggre-
gates of immunoglobulin G and A rapidly activated amolecules contain ankryn-like repeats that interact with
similar elements in Rel proteins and cover the nuclear NF-kB complex constituted of p50 and p65 subunits [8,
9]. IL-1b and TNF-a have also been shown to inducelocalization signal [4–6].
Following stimulation of cells by several stimuli, in- NF-kB activation in rodent and human mesangial cells [8,
10–17]. The generation of superoxide anion by xanthinecluding cytokines [for example, tumor necrosis factor-a
(TNF-a) and interleukin-1b (IL-1b)], lipopolysaccharide oxidase has been shown to induce NF-kB activation in
mouse mesangial cells [8]. However, neither hydrogen(LPS), immunoglobulin aggregates, or reactive oxygen
species (ROS), IkB is phosphorylated. Phosphorylation peroxide nor diamide were capable to induce NF-kB
activation in mouse or human mesangial cells [8, 18].of IkB occurs at two serine residues in the amino-termi-
nal portion of IkB proteins, probably through the action Hence, proinflammatory molecules that stimulate mes-
angial cell activation also induce NF-kB activation inof three newly described kinases (that is, NF-kB–
inducing kinase and IkB kinase a and b) and the intracel- such cells.
The importance of NF-kB activation in mesangial celllular production of ROS [4–6]. Phosphorylated IkB is
then ubiquitinated at nearby lysin residues and rapidly inflammation and proliferation has also been demon-
strated indirectly by the modulation of NF-kB activationdegraded by proteasomes [4–6].
The release of NF-kB from IkB results in the translo- in mesangial cell cultures. Rovin et al have demonstrated
that the inhibition of NF-kB activation by the proteasecation of NF-kB into the nucleus, where it binds to spe-
cific sequences in the promoter regions of target genes. inhibitor tosyl-phe-chloromethylketone, which prevents
the proteolytic degradation of IkB, or by an antisenseRemarkably, a large number of genes appear to be tar-
gets for the activation by NF-kB, among them those oligonucleotide to p65 was correlated with a dose-depen-
dent reduction in IL-1b–induced MCP-1 mRNA expres-coding for adhesion molecules [for example, vascular-
cell adhesion molecule-1 (VCAM-1) and intercellular sion in human mesangial cells [10]. Duque et al have
shown that human mesangial cell pretreatment with theadhesion molecule-1 (ICAM-1)], chemokines [for exam-
ple, monocyte chemoattractant protein-1 (MCP-1) and antioxidant pyrrolidine dithiocarbamate (PDTC) inhib-
ited NF-kB activation and MCP-1, IL-8, and interferon-IL-8], proinflammatory cytokines (for example, IL-1b
and IL-6), and inflammatory enzymes [for example, in- inducible protein 10 mRNA expression [9]. Kunz et al
found an association between the suppression of IL-1b–ducible nitric oxide synthase (iNOS) and phospholipase
A2 (PLA2)], which are involved in the inflammatory and induced iNOS expression and the reduction of NF-kB
activation by cyclosporine A in rat mesangial cells [11].proliferative responses of cells [4–6]. On the other hand,
NF-kB is involved in antiapoptotic genomic response, We recently reported that lovastatin, a 3-hydroxy-3-
methylglutaryl coenzyme A (HMG-CoA) inhibitor, pre-although the putative antiapoptotic genes that are acti-
vated by NF-kB in response to apoptotic stimuli (for vents LPS-induced NF-kB activation in mesangial cells
and that lovastatin inhibits mesangial cell expression andexample, TNF-a) remain to be identified [4–6]. It should
be noted that the IkB-a gene itself has a kB site and is production of MCP-1 and IL-6 (abstract; Massy et al,
J Am Soc Nephrol 7:1859, 1996) [7]. On the other hand,activated by NF-kB, thus leading to increased synthesis
of IkB-a and termination of NF-kB activation [4–6]. a recent study has shown that FK506 activated NF-kB
and induced the production of IL-6 in mouse mesangialThere are minor changes in the base composition of
the NF-kB sites and surrounding sequences, and it is cells (in contrast to the situation in T cells) [19]. Thus,
various experimental maneuvers that modulate NF-kBcooperation with other transcription factors, such as acti-
vator protein 1 (AP-1) and NF-IL6, may account for activation result in a parallel modulation of proinflam-
matory molecule production in mesangial cells (Fig. 1).subtle regulation of specific genes in different cell types.
In vivo evidence
NUCLEAR FACTOR-kB AND MESANGIAL
In animal models of renal disease, the effects of NF-kB
CELL ACTIVATION
modulation on mesangial cell activation have not been
In vitro evidence extensively evaluated [20–23]. Nevertheless, NF-kB acti-
vation has been shown in glomeruli of rats injected withSeveral studies have shown that the well-known in-
ducers of NF-kB activation also stimulate NF-kB activa- antiglomerular basement membrane sera [20, 21] and in
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Fig. 1. Schematic representation of the role of NF-kB in mesangial cell activation. Following stimulation of mesangial cells by cytokines, lipopolysac-
charide, immunoglobulin aggregates, angiotensin II, or reactive oxygen species, IkB is phosphorylated and degraded, releasing NF-kB for transloca-
tion to the nucleus where it is transcriptionally active. In the nucleus, NF-kB interacts with a number of promoters, among them those for adhesion
molecules, chemokines, proinflammatory cytokines, and inflammatory enzymes, which are involved in the inflammatory and proliferative responses
of mesangial cells. The use of various inhibitors of NF-kB activation results in a parallel reduction of the inflammatory response of mesangial cells.
Abbreviations are: ACEI, angiotensin-converting enzyme inhibitors; HMG-CoARI, hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
renal cortex of mice injected with LPS [22] and rats activation. Moreover, various experimental maneuvers
that inhibit NF-kB activation result in a parallel reduc-with immune complex nephritis [23]. Moreover, mRNA
expression of IL-1b, MCP-1, ICAM-1, and inducible tion of inflammatory response of mesangial cells. Collec-
tively, these data suggest a pivotal role of NF-kB inNOS was significantly induced by injection of antiglo-
merular basement membrane sera, and treatment with mesangial cell activation and designate this transcription
factor as an obvious target for the modulation of thisthe antioxidant PDTC inhibited the increase of glomeru-
lar NF-kB activity, followed by an inhibition of mRNA activation. However, these data need confirmation, par-
ticularly with respect to human renal injury. Moreover,expression of IL-1b, MCP-1, ICAM-1, and inducible
NOS in glomeruli [20]. In addition, PDTC decreased a selective and specific inhibitor(s) of NF-kB in mesan-
gial cell activation is warranted in order to avoid long-urinary protein excretion and protected renal function
in such rats [20]. In a similar model, treatment with term adverse consequences of suppression of such activa-
tion because NF-kB also plays a critical role in the hostprednisolone also prevented activation of NF-kB in glo-
meruli and subsequent mRNA expression of proin- defense.
flammatory molecules [21]. Likewise, the ability of the
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inhibiting the activation NF-kB has been recently dem-
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